Literature DB >> 11095345

Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.

S Agarwal1, K A Joyner, M W Swaim.   

Abstract

OBJECTIVES: Advanced liver disease is associated with both exaggerated fibrinolysis and with ascites. This study was undertaken to determine whether fibrinolytic activity exists in the ascites fluid of patients with liver disease and to see whether such activity is associated with evidence of plasma fibrinolysis.
METHODS: Both the ascites fluid and plasma from 15 patients with cirrhotic ascites (group A) were evaluated for markers of fibrinolysis: fragment D-dimer, plasminogen, fibrinogen, and fibrin split products. In addition, the euglobulin lysis time, a test highly specific for fibrinolysis, was evaluated in the ascites fluid samples. As a control group, the plasma from 15 cirrhotic patients without ascites (group B) was evaluated for markers of fibrinolysis.
RESULTS: In group A, elevated fragment D-dimer and fibrin split products were uniformly found in ascites fluid in concentrations that would be considered pathologically elevated if in plasma. Ascites fluid was also depleted, compared with plasma, of both plasminogen and fibrinogen. These results, along with the short euglobulin lysis time in 83% of the patients, suggest that increased fibrinolytic activity is present in ascites fluid. In 93% of these patients, plasma D-dimer was elevated. The mean plasma plasminogen was also low in these patients. In group B, only 33% of patients had elevated plasma D-dimer.
CONCLUSIONS: Ascites fluid has fibrinolytic activity. Because ascites fluid reenters the systemic circulation via the thoracic duct, via a natural peritoneovenous shunt, ascites fluid warrants serious consideration as a pathological fluid that contributes to the systemic fibrinolytic state found in the majority of our patients with ascites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095345     DOI: 10.1111/j.1572-0241.2000.03299.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  27 in total

1.  D-dimer for the diagnosis of acute venous thromboembolism in the emergency department: a Janus-face marker.

Authors:  Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 2.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis.

Authors:  Aldo Spadaro; Vincenza Tortorella; Carmela Morace; Agostino Fortiguerra; Paola Composto; Caterina Bonfiglio; Angela Alibrandi; Carmelo Luigiano; Giuseppe De Caro; Antonino Ajello; Oscar Ferrau; Maria-Antonietta Freni
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

Review 4.  Inflammatory status in human hepatic cirrhosis.

Authors:  María Martínez-Esparza; María Tristán-Manzano; Antonio J Ruiz-Alcaraz; Pilar García-Peñarrubia
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

5.  Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure.

Authors:  Ta-Wei Hsu; Yi-Chuan Chen; Meei-Ju Wu; Anna Fen-Yau Li; Wu-Chang Yang; Yee-Yung Ng
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-02-02

6.  Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.

Authors:  Francesca Romana Ponziani; Valerio De Stefano; Antonio Gasbarrini
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-30       Impact factor: 2.576

Review 7.  The hemostatic and thrombotic complications of liver disease.

Authors:  Hannah Stowe McMurry; Janice Jou; Joseph Shatzel
Journal:  Eur J Haematol       Date:  2021-07-29       Impact factor: 2.997

8.  Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion.

Authors:  Heiko Rühl; Christina Berens; Anna Winterhagen; Jens Müller; Johannes Oldenburg; Bernd Pötzsch
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

9.  Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.

Authors:  Nikolaj Torp; Mads Israelsen; Bjørn Madsen; Philipp Lutz; Christian Jansen; Christian Strassburg; Christian Mortensen; Anne Wilkens Knudsen; Grith Lykke Sorensen; Uffe Holmskov; Anders Schlosser; Maja Thiele; Jonel Trebicka; Aleksander Krag
Journal:  JHEP Rep       Date:  2021-03-29

10.  Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  Ahmed M El Gohary; Amany S Elyamany; Neveen L Mikhael; Mahmoud G Mahmoud; Marwa Mohamed Reda Tawfik
Journal:  Clin Exp Hepatol       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.